Literature DB >> 2474482

Antimitochondrial antibodies in primary biliary cirrhosis recognize both specific peptides and shared epitopes of the M2 family of antigens.

G R Flannery1, A K Burroughs, P Butler, J Chelliah, J Hamilton-Miller, W Brumfitt, H Baum.   

Abstract

Sera from patients with primary biliary cirrhosis exhibit variable autoantibody reactivity against mitochondria, the commonest antigen (designated M2) including three structures of approximate M.W. 70, 50 and 40 kD. The nature of these antigens has only recently been established; the 70 and 50 kD are the transacetylase E2 and component X, respectively, of the pyruvate dehydrogenase complex and are distinct polypeptides. We have demonstrated, by immunoblotting, elution and rebinding of antibodies, unequivocal cross-reactivity between the major bands of the M2 antigen. In addition, cross-reactivity has been shown between antibodies binding to each of the three M2 bands of mitochondria and two major antigenic bands of both Gram-negative and Gram-positive bacteria. Conversely, antibodies eluted from these two bands of Escherichia coli were found to bind all three M2 bands of mitochondria. These results suggest that the antibodies of primary biliary cirrhosis contain both peptide-specific and cross-reacting antibodies, the latter recognizing a common "M2 epitope" that might include nonprotein components of the peptides. However, direct and competitive enzyme-linked immunosorbent assays failed to implicate the coenzyme of the pyruvate dehydrogenase complex, lipoic acid or its amide, as the common antigenic moiety.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2474482     DOI: 10.1002/hep.1840100321

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  8 in total

Review 1.  Immunological abnormalities and hepatotropic viral infections.

Authors:  I G McFarlane
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

Review 2.  Molecular characterization of the mitochondrial autoantigens in primary biliary cirrhosis.

Authors:  P S Leung; J Van de Water; R L Coppel; M E Gershwin
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

Review 3.  Mitochondrial antigens and antibodies in primary biliary cirrhosis.

Authors:  P Butler; F Valle; A K Burroughs
Journal:  Postgrad Med J       Date:  1991-09       Impact factor: 2.401

Review 4.  Concept on the pathogenesis and treatment of primary biliary cirrhosis.

Authors:  Vasiliy-Ivanovich Reshetnyak
Journal:  World J Gastroenterol       Date:  2006-12-07       Impact factor: 5.742

5.  Reactivity of primary biliary cirrhosis sera with Escherichia coli dihydrolipoamide acetyltransferase (E2p): characterization of the main immunogenic region.

Authors:  S P Fussey; S T Ali; J R Guest; O F James; M F Bassendine; S J Yeaman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

6.  Anti-pyruvate dehydrogenase autoantibodies in primary biliary cirrhosis.

Authors:  N Zurgil; R Bakimer; M Kaplan; P Youinou; Y Shoenfeld
Journal:  J Clin Immunol       Date:  1991-09       Impact factor: 8.317

7.  Characterization and epitope mapping of human monoclonal antibodies to PDC-E2, the immunodominant autoantigen of primary biliary cirrhosis.

Authors:  P S Leung; S Krams; S Munoz; C P Surh; A Ansari; T Kenny; D L Robbins; J Fung; T E Starzl; W Maddrey
Journal:  J Autoimmun       Date:  1992-12       Impact factor: 7.094

8.  Natural history of bacteriuria in women with primary biliary cirrhosis and the effect of antimicrobial therapy in symptomatic and asymptomatic groups.

Authors:  P Butler; J M Hamilton-Miller; N McIntyre; A K Burroughs
Journal:  Gut       Date:  1995-06       Impact factor: 23.059

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.